Clinical trial
Kronos Early Estrogen Prevention Study (KEEPS)
NCT00154180 · Kronos Longevity Research Institute, Other · Unknown status
Key facts
| NCT number | NCT00154180 |
|---|---|
| Title | Kronos Early Estrogen Prevention Study (KEEPS) |
| Official title | Effects of Estrogen Replacement on Atherosclerosis Progression in Recently Menopausal Women |
| Lead sponsor | Kronos Longevity Research Institute, Other |
| Collaborators | Albert Einstein College of Medicine Brigham and Women's Hospital Columbia University Mayo Clinic University of California, San Francisco University of Utah University of Washington Yale University |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Menopause, Arteriosclerosis |
| Intervention type | Drug |
| Interventions | Conjugated equine estrogens 0.45 mg/day, Transdermal estradiol, 50 mcg/day, Micronized progesterone, 200 mg/day x 12 d/month, CEE, progesterone, estradiol patch or placebo for each, transdermal patch or the placebo |
| Enrollment | 728 |
| Start date | Sep 1, 2005 |
| Primary completion | May 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 14, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: